ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,291.34
0.15%
US Tech 100
18,225.20
0.28%
다우존스 지수
38,711.29
0.36%
Bitcoin
71,098.21
0.67%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Oyster Point Pharma Inc (OYST)

  7. Oyster Point Pharma Inc (OYST) 뉴스

OYST

Oyster Point Pharma (OYST)

Oyster Point Pharma Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:OYST
일자시간출처헤드라인심볼기업
2023/02/1506:34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OYSTOyster Point Pharma Inc
2023/02/1500:06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OYSTOyster Point Pharma Inc
2023/01/1407:11Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:OYSTOyster Point Pharma Inc
2023/01/1407:06Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OYSTOyster Point Pharma Inc
2023/01/0620:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OYSTOyster Point Pharma Inc
2023/01/0606:33Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OYSTOyster Point Pharma Inc
2023/01/0606:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
2023/01/0508:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
2023/01/0507:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
2023/01/0507:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
2023/01/0507:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
2023/01/0507:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
2023/01/0507:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
2023/01/0507:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
2023/01/0323:53Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:OYSTOyster Point Pharma Inc
2023/01/0323:26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OYSTOyster Point Pharma Inc
2023/01/0323:19Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:OYSTOyster Point Pharma Inc
2023/01/0323:07Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OYSTOyster Point Pharma Inc
2022/12/2320:31Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OYSTOyster Point Pharma Inc
2022/12/2307:16Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OYSTOyster Point Pharma Inc
2022/12/2120:04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OYSTOyster Point Pharma Inc
2022/12/0921:01Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OYSTOyster Point Pharma Inc
2022/12/0921:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OYSTOyster Point Pharma Inc
2022/12/0622:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
2022/12/0607:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
2022/12/0222:00GlobeNewswire Inc.Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OYSTOyster Point Pharma Inc
2022/12/0121:39Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OYSTOyster Point Pharma Inc
2022/12/0120:12Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:OYSTOyster Point Pharma Inc
2022/11/1706:25Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OYSTOyster Point Pharma Inc
2022/11/1422:10Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:OYSTOyster Point Pharma Inc
 검색 관련기사 보기:NASDAQ:OYST

최근 히스토리

NYSE
AXP
American Express
NYSE
DIS
Walt Disney
NYSE
MRK
Merck
COIN
ETHUSD
Ethereum
FX
USDEUR
US Dollar vs Euro
NYSE
NKE
Nike
CCOM
US500
US 500
NYSE
XOM
Exxon Mobil
NYSE
MCD
McDonalds
USOTC
BASFY
BASF (QX)
AMEX
XLF
Financial Select Sector
USOTC
RHHBY
Roche (QX)
COIN
SOLUSD
Solana
USOTC
ADDYY
Adidas (QX)
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유